Patents by Inventor Maxime Buffat

Maxime Buffat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Muscarinic agents as therapeutic compounds
    Patent number: 7691857
    Abstract: Muscarinic agonists of the formula (I) with M1 selectivity which are useful as agents for stimulating the cognitive functions of the brain.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: April 6, 2010
    Assignee: Muscagen Limited
    Inventors: Maxime Buffat, James Eric Thomas, Harvard Robin Davies
  • Muscarinic Agents as Therapeutic Compounds
    Publication number: 20080039469
    Abstract: Muscarinic agonists of the formula (I) with M1 selectivity which are useful as agents for stimulating the cognitive functions of the brain.
    Type: Application
    Filed: December 6, 2004
    Publication date: February 14, 2008
    Applicant: MUSCAGEN LIMITED
    Inventors: Maxime Buffat, Eric James Thomas, Robin Havard Davies